nodes	percent_of_prediction	percent_of_DWPC	metapath
Azelastine—HRH1—atherosclerosis	0.392	1	CbGaD
Azelastine—CYP2B6—Simvastatin—atherosclerosis	0.0275	0.0618	CbGbCtD
Azelastine—CYP3A5—Rosuvastatin—atherosclerosis	0.0233	0.0524	CbGbCtD
Azelastine—CYP3A5—Simvastatin—atherosclerosis	0.0216	0.0487	CbGbCtD
Azelastine—CYP3A5—Pravastatin—atherosclerosis	0.0212	0.0477	CbGbCtD
Azelastine—CYP3A5—Lovastatin—atherosclerosis	0.0212	0.0477	CbGbCtD
Azelastine—CYP2C8—Simvastatin—atherosclerosis	0.0208	0.0468	CbGbCtD
Azelastine—CYP2C8—Lovastatin—atherosclerosis	0.0204	0.0458	CbGbCtD
Azelastine—CYP2C8—Pravastatin—atherosclerosis	0.0204	0.0458	CbGbCtD
Azelastine—CYP2C19—Rosuvastatin—atherosclerosis	0.0188	0.0423	CbGbCtD
Azelastine—CYP2C19—Simvastatin—atherosclerosis	0.0175	0.0393	CbGbCtD
Azelastine—CYP2C19—Lovastatin—atherosclerosis	0.0171	0.0385	CbGbCtD
Azelastine—CYP2D6—Niacin—atherosclerosis	0.0168	0.0378	CbGbCtD
Azelastine—CYP2C9—Rosuvastatin—atherosclerosis	0.0156	0.0351	CbGbCtD
Azelastine—ABCB1—Ezetimibe—atherosclerosis	0.0151	0.0341	CbGbCtD
Azelastine—CYP2C9—Simvastatin—atherosclerosis	0.0145	0.0327	CbGbCtD
Azelastine—CYP2C9—Lovastatin—atherosclerosis	0.0142	0.032	CbGbCtD
Azelastine—CYP2C9—Pravastatin—atherosclerosis	0.0142	0.032	CbGbCtD
Azelastine—ABCB1—Simvastatin—atherosclerosis	0.0141	0.0317	CbGbCtD
Azelastine—ABCB1—Lovastatin—atherosclerosis	0.0138	0.031	CbGbCtD
Azelastine—ABCB1—Pravastatin—atherosclerosis	0.0138	0.031	CbGbCtD
Azelastine—CYP2D6—Simvastatin—atherosclerosis	0.0133	0.0299	CbGbCtD
Azelastine—CYP2D6—Pravastatin—atherosclerosis	0.013	0.0292	CbGbCtD
Azelastine—CYP2D6—Lovastatin—atherosclerosis	0.013	0.0292	CbGbCtD
Azelastine—CYP3A4—Rosuvastatin—atherosclerosis	0.00908	0.0204	CbGbCtD
Azelastine—CYP3A4—Ezetimibe—atherosclerosis	0.00908	0.0204	CbGbCtD
Azelastine—CYP3A4—Simvastatin—atherosclerosis	0.00844	0.019	CbGbCtD
Azelastine—CYP3A4—Pravastatin—atherosclerosis	0.00826	0.0186	CbGbCtD
Azelastine—CYP3A4—Lovastatin—atherosclerosis	0.00826	0.0186	CbGbCtD
Azelastine—Furunculosis—Niacin—atherosclerosis	0.00193	0.0221	CcSEcCtD
Azelastine—Furuncle—Niacin—atherosclerosis	0.00167	0.0192	CcSEcCtD
Azelastine—Laryngitis—Niacin—atherosclerosis	0.00114	0.013	CcSEcCtD
Azelastine—Viral infection—Ezetimibe—atherosclerosis	0.00104	0.0119	CcSEcCtD
Azelastine—Sleep disorder—Rosuvastatin—atherosclerosis	0.000944	0.0108	CcSEcCtD
Azelastine—Chlorcyclizine—HRH1—atherosclerosis	0.000942	0.236	CrCbGaD
Azelastine—Breast pain—Niacin—atherosclerosis	0.000939	0.0108	CcSEcCtD
Azelastine—Gastroenteritis—Rosuvastatin—atherosclerosis	0.000922	0.0106	CcSEcCtD
Azelastine—Buclizine—HRH1—atherosclerosis	0.000906	0.227	CrCbGaD
Azelastine—Viral infection—Pravastatin—atherosclerosis	0.000893	0.0102	CcSEcCtD
Azelastine—Meclizine—HRH1—atherosclerosis	0.000864	0.216	CrCbGaD
Azelastine—Clemastine—HRH1—atherosclerosis	0.000812	0.204	CrCbGaD
Azelastine—Dermatitis contact—Niacin—atherosclerosis	0.00081	0.00929	CcSEcCtD
Azelastine—Sleep disorder—Simvastatin—atherosclerosis	0.000748	0.00858	CcSEcCtD
Azelastine—Eczema—Simvastatin—atherosclerosis	0.000721	0.00827	CcSEcCtD
Azelastine—Abnormal vision—Niacin—atherosclerosis	0.000715	0.0082	CcSEcCtD
Azelastine—Arthritis—Lovastatin—atherosclerosis	0.000713	0.00817	CcSEcCtD
Azelastine—Arthritis—Ezetimibe—atherosclerosis	0.000699	0.00802	CcSEcCtD
Azelastine—Atrial fibrillation—Simvastatin—atherosclerosis	0.000684	0.00784	CcSEcCtD
Azelastine—Bronchitis—Rosuvastatin—atherosclerosis	0.000679	0.00779	CcSEcCtD
Azelastine—Sleep disorder—Pravastatin—atherosclerosis	0.000677	0.00776	CcSEcCtD
Azelastine—Arthritis—Simvastatin—atherosclerosis	0.000667	0.00764	CcSEcCtD
Azelastine—Eczema—Niacin—atherosclerosis	0.000662	0.00759	CcSEcCtD
Azelastine—Atrial fibrillation—Niacin—atherosclerosis	0.000628	0.0072	CcSEcCtD
Azelastine—Arthritis—Niacin—atherosclerosis	0.000612	0.00702	CcSEcCtD
Azelastine—Nasopharyngitis—Ezetimibe—atherosclerosis	0.000607	0.00697	CcSEcCtD
Azelastine—Arthritis—Pravastatin—atherosclerosis	0.000603	0.00691	CcSEcCtD
Azelastine—Haematuria—Rosuvastatin—atherosclerosis	0.0006	0.00689	CcSEcCtD
Azelastine—Alanine aminotransferase increased—Ezetimibe—atherosclerosis	0.000599	0.00687	CcSEcCtD
Azelastine—Sinusitis—Rosuvastatin—atherosclerosis	0.000591	0.00678	CcSEcCtD
Azelastine—Face oedema—Niacin—atherosclerosis	0.000574	0.00659	CcSEcCtD
Azelastine—Rhinitis—Rosuvastatin—atherosclerosis	0.000567	0.0065	CcSEcCtD
Azelastine—Urinary retention—Niacin—atherosclerosis	0.000566	0.00649	CcSEcCtD
Azelastine—Pharyngitis—Rosuvastatin—atherosclerosis	0.000561	0.00644	CcSEcCtD
Azelastine—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.000546	0.00626	CcSEcCtD
Azelastine—Bronchitis—Simvastatin—atherosclerosis	0.000538	0.00618	CcSEcCtD
Azelastine—Nasopharyngitis—Pravastatin—atherosclerosis	0.000524	0.00601	CcSEcCtD
Azelastine—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.00052	0.00597	CcSEcCtD
Azelastine—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.000517	0.00592	CcSEcCtD
Azelastine—Sinusitis—Lovastatin—atherosclerosis	0.000501	0.00574	CcSEcCtD
Azelastine—Bronchitis—Niacin—atherosclerosis	0.000494	0.00567	CcSEcCtD
Azelastine—Sinusitis—Ezetimibe—atherosclerosis	0.000491	0.00563	CcSEcCtD
Azelastine—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.00047	0.0054	CcSEcCtD
Azelastine—Sinusitis—Simvastatin—atherosclerosis	0.000468	0.00537	CcSEcCtD
Azelastine—Pharyngitis—Ezetimibe—atherosclerosis	0.000466	0.00535	CcSEcCtD
Azelastine—Weight increased—Pravastatin—atherosclerosis	0.000461	0.00528	CcSEcCtD
Azelastine—Flushing—Lovastatin—atherosclerosis	0.000445	0.0051	CcSEcCtD
Azelastine—Flushing—Ezetimibe—atherosclerosis	0.000436	0.005	CcSEcCtD
Azelastine—Cough—Rosuvastatin—atherosclerosis	0.000429	0.00493	CcSEcCtD
Azelastine—Sinusitis—Pravastatin—atherosclerosis	0.000423	0.00486	CcSEcCtD
Azelastine—Myalgia—Rosuvastatin—atherosclerosis	0.000419	0.00481	CcSEcCtD
Azelastine—Flushing—Simvastatin—atherosclerosis	0.000416	0.00477	CcSEcCtD
Azelastine—Rhinitis—Niacin—atherosclerosis	0.000413	0.00473	CcSEcCtD
Azelastine—Hypoaesthesia—Niacin—atherosclerosis	0.000409	0.0047	CcSEcCtD
Azelastine—Dysgeusia—Lovastatin—atherosclerosis	0.000408	0.00468	CcSEcCtD
Azelastine—Rhinitis—Pravastatin—atherosclerosis	0.000406	0.00466	CcSEcCtD
Azelastine—Confusional state—Rosuvastatin—atherosclerosis	0.000405	0.00464	CcSEcCtD
Azelastine—Back pain—Lovastatin—atherosclerosis	0.000403	0.00463	CcSEcCtD
Azelastine—Hypoaesthesia—Pravastatin—atherosclerosis	0.000403	0.00462	CcSEcCtD
Azelastine—Pharyngitis—Pravastatin—atherosclerosis	0.000402	0.00461	CcSEcCtD
Azelastine—Infection—Rosuvastatin—atherosclerosis	0.000399	0.00458	CcSEcCtD
Azelastine—Visual impairment—Niacin—atherosclerosis	0.000397	0.00455	CcSEcCtD
Azelastine—Back pain—Ezetimibe—atherosclerosis	0.000396	0.00454	CcSEcCtD
Azelastine—Vision blurred—Lovastatin—atherosclerosis	0.000393	0.00451	CcSEcCtD
Azelastine—Visual impairment—Pravastatin—atherosclerosis	0.00039	0.00448	CcSEcCtD
Azelastine—Ill-defined disorder—Lovastatin—atherosclerosis	0.000387	0.00444	CcSEcCtD
Azelastine—Eye disorder—Niacin—atherosclerosis	0.000385	0.00441	CcSEcCtD
Azelastine—Dysgeusia—Simvastatin—atherosclerosis	0.000382	0.00438	CcSEcCtD
Azelastine—Flushing—Niacin—atherosclerosis	0.000382	0.00438	CcSEcCtD
Azelastine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00038	0.00435	CcSEcCtD
Azelastine—Malaise—Lovastatin—atherosclerosis	0.000376	0.00431	CcSEcCtD
Azelastine—Flushing—Pravastatin—atherosclerosis	0.000376	0.00431	CcSEcCtD
Azelastine—Vertigo—Lovastatin—atherosclerosis	0.000375	0.0043	CcSEcCtD
Azelastine—Malaise—Ezetimibe—atherosclerosis	0.000369	0.00423	CcSEcCtD
Azelastine—Vision blurred—Simvastatin—atherosclerosis	0.000368	0.00422	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000366	0.0042	CcSEcCtD
Azelastine—Ill-defined disorder—Simvastatin—atherosclerosis	0.000362	0.00415	CcSEcCtD
Azelastine—Palpitations—Ezetimibe—atherosclerosis	0.000361	0.00415	CcSEcCtD
Azelastine—Paraesthesia—Rosuvastatin—atherosclerosis	0.000361	0.00414	CcSEcCtD
Azelastine—Cough—Ezetimibe—atherosclerosis	0.000357	0.00409	CcSEcCtD
Azelastine—Myalgia—Lovastatin—atherosclerosis	0.000355	0.00407	CcSEcCtD
Azelastine—Chest pain—Lovastatin—atherosclerosis	0.000355	0.00407	CcSEcCtD
Azelastine—Anxiety—Lovastatin—atherosclerosis	0.000354	0.00406	CcSEcCtD
Azelastine—Hypertension—Ezetimibe—atherosclerosis	0.000353	0.00405	CcSEcCtD
Azelastine—Malaise—Simvastatin—atherosclerosis	0.000352	0.00403	CcSEcCtD
Azelastine—Tension—Niacin—atherosclerosis	0.000352	0.00403	CcSEcCtD
Azelastine—Discomfort—Lovastatin—atherosclerosis	0.000351	0.00402	CcSEcCtD
Azelastine—Vertigo—Simvastatin—atherosclerosis	0.00035	0.00402	CcSEcCtD
Azelastine—Myalgia—Ezetimibe—atherosclerosis	0.000348	0.00399	CcSEcCtD
Azelastine—Chest pain—Ezetimibe—atherosclerosis	0.000348	0.00399	CcSEcCtD
Azelastine—Nervousness—Niacin—atherosclerosis	0.000348	0.00399	CcSEcCtD
Azelastine—Dry mouth—Lovastatin—atherosclerosis	0.000347	0.00398	CcSEcCtD
Azelastine—Tension—Pravastatin—atherosclerosis	0.000346	0.00397	CcSEcCtD
Azelastine—Dysgeusia—Pravastatin—atherosclerosis	0.000345	0.00396	CcSEcCtD
Azelastine—Discomfort—Ezetimibe—atherosclerosis	0.000344	0.00395	CcSEcCtD
Azelastine—Constipation—Rosuvastatin—atherosclerosis	0.000343	0.00394	CcSEcCtD
Azelastine—Pain—Rosuvastatin—atherosclerosis	0.000343	0.00394	CcSEcCtD
Azelastine—Confusional state—Lovastatin—atherosclerosis	0.000343	0.00394	CcSEcCtD
Azelastine—Nervousness—Pravastatin—atherosclerosis	0.000343	0.00393	CcSEcCtD
Azelastine—Dry mouth—Ezetimibe—atherosclerosis	0.000341	0.00391	CcSEcCtD
Azelastine—Anaphylactic shock—Lovastatin—atherosclerosis	0.00034	0.0039	CcSEcCtD
Azelastine—Infection—Lovastatin—atherosclerosis	0.000338	0.00388	CcSEcCtD
Azelastine—Vision blurred—Niacin—atherosclerosis	0.000338	0.00387	CcSEcCtD
Azelastine—Confusional state—Ezetimibe—atherosclerosis	0.000337	0.00386	CcSEcCtD
Azelastine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000334	0.00383	CcSEcCtD
Azelastine—Vision blurred—Pravastatin—atherosclerosis	0.000332	0.00381	CcSEcCtD
Azelastine—Chest pain—Simvastatin—atherosclerosis	0.000332	0.00381	CcSEcCtD
Azelastine—Myalgia—Simvastatin—atherosclerosis	0.000332	0.00381	CcSEcCtD
Azelastine—Infection—Ezetimibe—atherosclerosis	0.000332	0.0038	CcSEcCtD
Azelastine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000331	0.0038	CcSEcCtD
Azelastine—Anxiety—Simvastatin—atherosclerosis	0.000331	0.0038	CcSEcCtD
Azelastine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000328	0.00377	CcSEcCtD
Azelastine—Discomfort—Simvastatin—atherosclerosis	0.000328	0.00376	CcSEcCtD
Azelastine—Ill-defined disorder—Pravastatin—atherosclerosis	0.000327	0.00375	CcSEcCtD
Azelastine—Vertigo—Niacin—atherosclerosis	0.000322	0.00369	CcSEcCtD
Azelastine—Confusional state—Simvastatin—atherosclerosis	0.000321	0.00368	CcSEcCtD
Azelastine—Anaphylactic shock—Simvastatin—atherosclerosis	0.000318	0.00365	CcSEcCtD
Azelastine—Malaise—Pravastatin—atherosclerosis	0.000318	0.00365	CcSEcCtD
Azelastine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000318	0.00364	CcSEcCtD
Azelastine—Vertigo—Pravastatin—atherosclerosis	0.000317	0.00363	CcSEcCtD
Azelastine—Palpitations—Niacin—atherosclerosis	0.000317	0.00363	CcSEcCtD
Azelastine—Infection—Simvastatin—atherosclerosis	0.000316	0.00363	CcSEcCtD
Azelastine—Cough—Niacin—atherosclerosis	0.000313	0.00358	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00031	0.00356	CcSEcCtD
Azelastine—Cough—Pravastatin—atherosclerosis	0.000308	0.00353	CcSEcCtD
Azelastine—Paraesthesia—Lovastatin—atherosclerosis	0.000306	0.00351	CcSEcCtD
Azelastine—Myalgia—Niacin—atherosclerosis	0.000305	0.0035	CcSEcCtD
Azelastine—Hypertension—Pravastatin—atherosclerosis	0.000304	0.00349	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000304	0.00349	CcSEcCtD
Azelastine—Dyspnoea—Lovastatin—atherosclerosis	0.000303	0.00348	CcSEcCtD
Azelastine—Myalgia—Pravastatin—atherosclerosis	0.0003	0.00344	CcSEcCtD
Azelastine—Chest pain—Pravastatin—atherosclerosis	0.0003	0.00344	CcSEcCtD
Azelastine—Paraesthesia—Ezetimibe—atherosclerosis	0.0003	0.00344	CcSEcCtD
Azelastine—Anxiety—Pravastatin—atherosclerosis	0.000299	0.00343	CcSEcCtD
Azelastine—Dry mouth—Niacin—atherosclerosis	0.000298	0.00342	CcSEcCtD
Azelastine—Dyspnoea—Ezetimibe—atherosclerosis	0.000298	0.00341	CcSEcCtD
Azelastine—Discomfort—Pravastatin—atherosclerosis	0.000297	0.0034	CcSEcCtD
Azelastine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000296	0.00339	CcSEcCtD
Azelastine—Fatigue—Lovastatin—atherosclerosis	0.000293	0.00337	CcSEcCtD
Azelastine—Anaphylactic shock—Niacin—atherosclerosis	0.000292	0.00335	CcSEcCtD
Azelastine—Pain—Lovastatin—atherosclerosis	0.000291	0.00334	CcSEcCtD
Azelastine—Constipation—Lovastatin—atherosclerosis	0.000291	0.00334	CcSEcCtD
Azelastine—Confusional state—Pravastatin—atherosclerosis	0.00029	0.00333	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00029	0.00333	CcSEcCtD
Azelastine—Asthenia—Rosuvastatin—atherosclerosis	0.000288	0.00331	CcSEcCtD
Azelastine—Anaphylactic shock—Pravastatin—atherosclerosis	0.000288	0.0033	CcSEcCtD
Azelastine—Fatigue—Ezetimibe—atherosclerosis	0.000288	0.0033	CcSEcCtD
Azelastine—Infection—Pravastatin—atherosclerosis	0.000286	0.00328	CcSEcCtD
Azelastine—Paraesthesia—Simvastatin—atherosclerosis	0.000286	0.00328	CcSEcCtD
Azelastine—Pain—Ezetimibe—atherosclerosis	0.000285	0.00327	CcSEcCtD
Azelastine—Constipation—Ezetimibe—atherosclerosis	0.000285	0.00327	CcSEcCtD
Azelastine—Tachycardia—Niacin—atherosclerosis	0.000285	0.00327	CcSEcCtD
Azelastine—Pruritus—Rosuvastatin—atherosclerosis	0.000284	0.00326	CcSEcCtD
Azelastine—Dyspnoea—Simvastatin—atherosclerosis	0.000284	0.00326	CcSEcCtD
Azelastine—Feeling abnormal—Lovastatin—atherosclerosis	0.00028	0.00322	CcSEcCtD
Azelastine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000278	0.00319	CcSEcCtD
Azelastine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000275	0.00316	CcSEcCtD
Azelastine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000275	0.00315	CcSEcCtD
Azelastine—Fatigue—Simvastatin—atherosclerosis	0.000274	0.00315	CcSEcCtD
Azelastine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000273	0.00313	CcSEcCtD
Azelastine—Pain—Simvastatin—atherosclerosis	0.000272	0.00312	CcSEcCtD
Azelastine—Constipation—Simvastatin—atherosclerosis	0.000272	0.00312	CcSEcCtD
Azelastine—Body temperature increased—Lovastatin—atherosclerosis	0.000269	0.00309	CcSEcCtD
Azelastine—Abdominal pain—Lovastatin—atherosclerosis	0.000269	0.00309	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000266	0.00305	CcSEcCtD
Azelastine—Dizziness—Rosuvastatin—atherosclerosis	0.000266	0.00305	CcSEcCtD
Azelastine—Body temperature increased—Ezetimibe—atherosclerosis	0.000264	0.00303	CcSEcCtD
Azelastine—Abdominal pain—Ezetimibe—atherosclerosis	0.000264	0.00303	CcSEcCtD
Azelastine—Paraesthesia—Niacin—atherosclerosis	0.000263	0.00301	CcSEcCtD
Azelastine—Feeling abnormal—Simvastatin—atherosclerosis	0.000262	0.00301	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000262	0.00301	CcSEcCtD
Azelastine—Dyspnoea—Niacin—atherosclerosis	0.000261	0.00299	CcSEcCtD
Azelastine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00026	0.00299	CcSEcCtD
Azelastine—Somnolence—Niacin—atherosclerosis	0.00026	0.00298	CcSEcCtD
Azelastine—Paraesthesia—Pravastatin—atherosclerosis	0.000258	0.00296	CcSEcCtD
Azelastine—Dyspnoea—Pravastatin—atherosclerosis	0.000257	0.00294	CcSEcCtD
Azelastine—Loxapine—HRH1—atherosclerosis	0.000254	0.0636	CrCbGaD
Azelastine—Rash—Rosuvastatin—atherosclerosis	0.000253	0.0029	CcSEcCtD
Azelastine—Dermatitis—Rosuvastatin—atherosclerosis	0.000253	0.0029	CcSEcCtD
Azelastine—Abdominal pain—Simvastatin—atherosclerosis	0.000252	0.00289	CcSEcCtD
Azelastine—Body temperature increased—Simvastatin—atherosclerosis	0.000252	0.00289	CcSEcCtD
Azelastine—Headache—Rosuvastatin—atherosclerosis	0.000252	0.00289	CcSEcCtD
Azelastine—Hypersensitivity—Lovastatin—atherosclerosis	0.000251	0.00288	CcSEcCtD
Azelastine—Pain—Niacin—atherosclerosis	0.00025	0.00287	CcSEcCtD
Azelastine—Fatigue—Pravastatin—atherosclerosis	0.000248	0.00285	CcSEcCtD
Azelastine—Constipation—Pravastatin—atherosclerosis	0.000246	0.00282	CcSEcCtD
Azelastine—Pain—Pravastatin—atherosclerosis	0.000246	0.00282	CcSEcCtD
Azelastine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000246	0.00282	CcSEcCtD
Azelastine—Asthenia—Lovastatin—atherosclerosis	0.000244	0.0028	CcSEcCtD
Azelastine—Pruritus—Lovastatin—atherosclerosis	0.000241	0.00276	CcSEcCtD
Azelastine—Asthenia—Ezetimibe—atherosclerosis	0.00024	0.00275	CcSEcCtD
Azelastine—Gastrointestinal pain—Niacin—atherosclerosis	0.000239	0.00274	CcSEcCtD
Azelastine—Nausea—Rosuvastatin—atherosclerosis	0.000239	0.00274	CcSEcCtD
Azelastine—Feeling abnormal—Pravastatin—atherosclerosis	0.000237	0.00272	CcSEcCtD
Azelastine—Pruritus—Ezetimibe—atherosclerosis	0.000236	0.00271	CcSEcCtD
Azelastine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000235	0.0027	CcSEcCtD
Azelastine—Hypersensitivity—Simvastatin—atherosclerosis	0.000235	0.00269	CcSEcCtD
Azelastine—Diarrhoea—Lovastatin—atherosclerosis	0.000233	0.00267	CcSEcCtD
Azelastine—Abdominal pain—Niacin—atherosclerosis	0.000231	0.00265	CcSEcCtD
Azelastine—Body temperature increased—Niacin—atherosclerosis	0.000231	0.00265	CcSEcCtD
Azelastine—Asthenia—Simvastatin—atherosclerosis	0.000228	0.00262	CcSEcCtD
Azelastine—Diarrhoea—Ezetimibe—atherosclerosis	0.000228	0.00262	CcSEcCtD
Azelastine—Abdominal pain—Pravastatin—atherosclerosis	0.000228	0.00261	CcSEcCtD
Azelastine—Body temperature increased—Pravastatin—atherosclerosis	0.000228	0.00261	CcSEcCtD
Azelastine—Pruritus—Simvastatin—atherosclerosis	0.000225	0.00258	CcSEcCtD
Azelastine—Dizziness—Lovastatin—atherosclerosis	0.000225	0.00258	CcSEcCtD
Azelastine—Dizziness—Ezetimibe—atherosclerosis	0.000221	0.00253	CcSEcCtD
Azelastine—Diarrhoea—Simvastatin—atherosclerosis	0.000218	0.0025	CcSEcCtD
Azelastine—Vomiting—Lovastatin—atherosclerosis	0.000216	0.00248	CcSEcCtD
Azelastine—Hypersensitivity—Niacin—atherosclerosis	0.000215	0.00247	CcSEcCtD
Azelastine—Rash—Lovastatin—atherosclerosis	0.000215	0.00246	CcSEcCtD
Azelastine—Dermatitis—Lovastatin—atherosclerosis	0.000214	0.00246	CcSEcCtD
Azelastine—Clozapine—HRH1—atherosclerosis	0.000213	0.0534	CrCbGaD
Azelastine—Headache—Lovastatin—atherosclerosis	0.000213	0.00245	CcSEcCtD
Azelastine—Vomiting—Ezetimibe—atherosclerosis	0.000212	0.00243	CcSEcCtD
Azelastine—Hypersensitivity—Pravastatin—atherosclerosis	0.000212	0.00243	CcSEcCtD
Azelastine—Dizziness—Simvastatin—atherosclerosis	0.000211	0.00241	CcSEcCtD
Azelastine—Rash—Ezetimibe—atherosclerosis	0.000211	0.00241	CcSEcCtD
Azelastine—Dermatitis—Ezetimibe—atherosclerosis	0.00021	0.00241	CcSEcCtD
Azelastine—Asthenia—Niacin—atherosclerosis	0.00021	0.00241	CcSEcCtD
Azelastine—Headache—Ezetimibe—atherosclerosis	0.000209	0.0024	CcSEcCtD
Azelastine—Pruritus—Niacin—atherosclerosis	0.000207	0.00237	CcSEcCtD
Azelastine—Asthenia—Pravastatin—atherosclerosis	0.000207	0.00237	CcSEcCtD
Azelastine—Pruritus—Pravastatin—atherosclerosis	0.000204	0.00234	CcSEcCtD
Azelastine—Vomiting—Simvastatin—atherosclerosis	0.000202	0.00232	CcSEcCtD
Azelastine—Nausea—Lovastatin—atherosclerosis	0.000202	0.00232	CcSEcCtD
Azelastine—Rash—Simvastatin—atherosclerosis	0.000201	0.0023	CcSEcCtD
Azelastine—Dermatitis—Simvastatin—atherosclerosis	0.000201	0.0023	CcSEcCtD
Azelastine—Diarrhoea—Niacin—atherosclerosis	0.0002	0.00229	CcSEcCtD
Azelastine—Headache—Simvastatin—atherosclerosis	0.000199	0.00229	CcSEcCtD
Azelastine—Nausea—Ezetimibe—atherosclerosis	0.000198	0.00227	CcSEcCtD
Azelastine—Diarrhoea—Pravastatin—atherosclerosis	0.000197	0.00226	CcSEcCtD
Azelastine—Dizziness—Niacin—atherosclerosis	0.000193	0.00222	CcSEcCtD
Azelastine—Dizziness—Pravastatin—atherosclerosis	0.00019	0.00218	CcSEcCtD
Azelastine—Nausea—Simvastatin—atherosclerosis	0.000189	0.00217	CcSEcCtD
Azelastine—Vomiting—Niacin—atherosclerosis	0.000186	0.00213	CcSEcCtD
Azelastine—Rash—Niacin—atherosclerosis	0.000184	0.00211	CcSEcCtD
Azelastine—Dermatitis—Niacin—atherosclerosis	0.000184	0.00211	CcSEcCtD
Azelastine—Headache—Niacin—atherosclerosis	0.000183	0.0021	CcSEcCtD
Azelastine—Vomiting—Pravastatin—atherosclerosis	0.000183	0.0021	CcSEcCtD
Azelastine—Rash—Pravastatin—atherosclerosis	0.000181	0.00208	CcSEcCtD
Azelastine—Dermatitis—Pravastatin—atherosclerosis	0.000181	0.00208	CcSEcCtD
Azelastine—Headache—Pravastatin—atherosclerosis	0.00018	0.00207	CcSEcCtD
Azelastine—Nausea—Niacin—atherosclerosis	0.000174	0.00199	CcSEcCtD
Azelastine—Nausea—Pravastatin—atherosclerosis	0.000171	0.00196	CcSEcCtD
Azelastine—CYP2C9—Metabolism—ABCA1—atherosclerosis	4.72e-06	6.53e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—CD36—atherosclerosis	4.71e-06	6.53e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	4.66e-06	6.45e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PPARA—atherosclerosis	4.65e-06	6.43e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	4.65e-06	6.43e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—ESR1—atherosclerosis	4.65e-06	6.43e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PPARA—atherosclerosis	4.64e-06	6.42e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—GSTM1—atherosclerosis	4.63e-06	6.41e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PDGFB—atherosclerosis	4.6e-06	6.38e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—AGT—atherosclerosis	4.6e-06	6.36e-05	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—AKT1—atherosclerosis	4.59e-06	6.36e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—F2—atherosclerosis	4.59e-06	6.35e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—LPL—atherosclerosis	4.55e-06	6.3e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—HMGCR—atherosclerosis	4.52e-06	6.26e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—APOE—atherosclerosis	4.5e-06	6.23e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—AGT—atherosclerosis	4.5e-06	6.23e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—AGT—atherosclerosis	4.5e-06	6.22e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—AGT—atherosclerosis	4.49e-06	6.22e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ALOX5—atherosclerosis	4.49e-06	6.21e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—MTHFR—atherosclerosis	4.47e-06	6.18e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—CAV1—atherosclerosis	4.46e-06	6.18e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—APOA1—atherosclerosis	4.45e-06	6.16e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—HMOX1—atherosclerosis	4.44e-06	6.14e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—GPX1—atherosclerosis	4.44e-06	6.14e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—APOE—atherosclerosis	4.41e-06	6.11e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—LEP—atherosclerosis	4.4e-06	6.1e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—APOE—atherosclerosis	4.4e-06	6.1e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—APOE—atherosclerosis	4.4e-06	6.09e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PIK3CG—atherosclerosis	4.39e-06	6.08e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PPARA—atherosclerosis	4.38e-06	6.07e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—ALB—atherosclerosis	4.37e-06	6.05e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—CAV1—atherosclerosis	4.37e-06	6.05e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CAV1—atherosclerosis	4.36e-06	6.04e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—CAV1—atherosclerosis	4.36e-06	6.04e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—APOA1—atherosclerosis	4.36e-06	6.04e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—APOA1—atherosclerosis	4.35e-06	6.03e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—APOA1—atherosclerosis	4.35e-06	6.02e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—HMOX1—atherosclerosis	4.33e-06	6e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—CD36—atherosclerosis	4.32e-06	5.98e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—APOB—atherosclerosis	4.25e-06	5.89e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—AGT—atherosclerosis	4.24e-06	5.87e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—MAPK3—atherosclerosis	4.21e-06	5.82e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—ESR1—atherosclerosis	4.21e-06	5.82e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—NOS3—atherosclerosis	4.18e-06	5.79e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—APOE—atherosclerosis	4.16e-06	5.76e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—INS—atherosclerosis	4.16e-06	5.75e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—F2—atherosclerosis	4.15e-06	5.75e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—APOB—atherosclerosis	4.15e-06	5.74e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—GSTM1—atherosclerosis	4.14e-06	5.73e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—CAV1—atherosclerosis	4.12e-06	5.7e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—APOA1—atherosclerosis	4.11e-06	5.69e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—MTHFR—atherosclerosis	4.09e-06	5.67e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CCL2—atherosclerosis	4.09e-06	5.66e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—HMOX1—atherosclerosis	4.08e-06	5.65e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	4.08e-06	5.65e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PIK3CG—atherosclerosis	4.06e-06	5.63e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—LPL—atherosclerosis	4.06e-06	5.62e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—HMOX1—atherosclerosis	4.05e-06	5.6e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—GSTM1—atherosclerosis	4.04e-06	5.59e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—ABCA1—atherosclerosis	4.03e-06	5.58e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—NAMPT—atherosclerosis	4.03e-06	5.57e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IGF1—atherosclerosis	4.02e-06	5.57e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PPARA—atherosclerosis	4.02e-06	5.56e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—LIPC—atherosclerosis	4e-06	5.54e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PIK3CG—atherosclerosis	3.98e-06	5.51e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—APOC3—atherosclerosis	3.98e-06	5.5e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PIK3CG—atherosclerosis	3.98e-06	5.5e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PIK3CG—atherosclerosis	3.97e-06	5.5e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—LPL—atherosclerosis	3.96e-06	5.49e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—GPX1—atherosclerosis	3.96e-06	5.48e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—LDLR—atherosclerosis	3.95e-06	5.47e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PPARG—atherosclerosis	3.92e-06	5.43e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—APOB—atherosclerosis	3.91e-06	5.41e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—AGT—atherosclerosis	3.89e-06	5.39e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—APOB—atherosclerosis	3.88e-06	5.37e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—GPX1—atherosclerosis	3.87e-06	5.35e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CETP—atherosclerosis	3.86e-06	5.34e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—CD36—atherosclerosis	3.86e-06	5.34e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—INS—atherosclerosis	3.85e-06	5.33e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PPARG—atherosclerosis	3.84e-06	5.32e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PPARG—atherosclerosis	3.83e-06	5.31e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PTGS2—atherosclerosis	3.82e-06	5.29e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—SERPINE1—atherosclerosis	3.82e-06	5.29e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—APOE—atherosclerosis	3.81e-06	5.28e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—MAPK3—atherosclerosis	3.81e-06	5.27e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—GSTM1—atherosclerosis	3.8e-06	5.27e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—CAV1—atherosclerosis	3.78e-06	5.23e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—GSTM1—atherosclerosis	3.77e-06	5.22e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—APOA1—atherosclerosis	3.77e-06	5.22e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—INS—atherosclerosis	3.77e-06	5.22e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CD36—atherosclerosis	3.76e-06	5.21e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—INS—atherosclerosis	3.76e-06	5.21e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—INS—atherosclerosis	3.76e-06	5.21e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PIK3CG—atherosclerosis	3.75e-06	5.2e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—LPL—atherosclerosis	3.73e-06	5.17e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CCL2—atherosclerosis	3.7e-06	5.13e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—LPL—atherosclerosis	3.7e-06	5.12e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—SCARB1—atherosclerosis	3.7e-06	5.12e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—MTHFR—atherosclerosis	3.65e-06	5.06e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—NOS3—atherosclerosis	3.65e-06	5.05e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—GPX1—atherosclerosis	3.64e-06	5.04e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IGF1—atherosclerosis	3.64e-06	5.04e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PPARG—atherosclerosis	3.62e-06	5.01e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—GPX1—atherosclerosis	3.61e-06	5e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PPARA—atherosclerosis	3.59e-06	4.96e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—MTHFR—atherosclerosis	3.57e-06	4.94e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—INS—atherosclerosis	3.55e-06	4.92e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CD36—atherosclerosis	3.55e-06	4.91e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—ALB—atherosclerosis	3.53e-06	4.88e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CD36—atherosclerosis	3.52e-06	4.87e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PPARA—atherosclerosis	3.5e-06	4.85e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—HMGCR—atherosclerosis	3.49e-06	4.83e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—AGT—atherosclerosis	3.47e-06	4.81e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—HMOX1—atherosclerosis	3.46e-06	4.79e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—SERPINE1—atherosclerosis	3.46e-06	4.78e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—ALB—atherosclerosis	3.45e-06	4.78e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—ALB—atherosclerosis	3.45e-06	4.77e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PIK3CG—atherosclerosis	3.44e-06	4.76e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—APOE—atherosclerosis	3.4e-06	4.71e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—AGT—atherosclerosis	3.39e-06	4.69e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—NOS3—atherosclerosis	3.37e-06	4.67e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—CAV1—atherosclerosis	3.37e-06	4.67e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—APOA1—atherosclerosis	3.36e-06	4.66e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—MTHFR—atherosclerosis	3.36e-06	4.65e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—MTHFR—atherosclerosis	3.33e-06	4.61e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—APOE—atherosclerosis	3.32e-06	4.6e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PPARG—atherosclerosis	3.32e-06	4.6e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—APOB—atherosclerosis	3.31e-06	4.59e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—NOS3—atherosclerosis	3.3e-06	4.57e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—NOS3—atherosclerosis	3.3e-06	4.57e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PPARA—atherosclerosis	3.3e-06	4.57e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—NOS3—atherosclerosis	3.3e-06	4.56e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CAV1—atherosclerosis	3.29e-06	4.56e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—APOA1—atherosclerosis	3.28e-06	4.55e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PPARA—atherosclerosis	3.27e-06	4.53e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—INS—atherosclerosis	3.26e-06	4.51e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—ALB—atherosclerosis	3.26e-06	4.51e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CXCL8—atherosclerosis	3.23e-06	4.48e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—GSTM1—atherosclerosis	3.22e-06	4.46e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—AGT—atherosclerosis	3.19e-06	4.42e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—AGT—atherosclerosis	3.17e-06	4.38e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—LPL—atherosclerosis	3.16e-06	4.38e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—APOE—atherosclerosis	3.13e-06	4.33e-05	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—AKT1—atherosclerosis	3.12e-06	4.32e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—NOS3—atherosclerosis	3.11e-06	4.31e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ABCA1—atherosclerosis	3.11e-06	4.31e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—APOE—atherosclerosis	3.1e-06	4.3e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CAV1—atherosclerosis	3.1e-06	4.29e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—APOA1—atherosclerosis	3.09e-06	4.28e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—GPX1—atherosclerosis	3.09e-06	4.27e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PTGS2—atherosclerosis	3.09e-06	4.27e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—IL6—atherosclerosis	3.07e-06	4.26e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CAV1—atherosclerosis	3.07e-06	4.26e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PIK3CG—atherosclerosis	3.07e-06	4.25e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—APOA1—atherosclerosis	3.07e-06	4.25e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PTGS2—atherosclerosis	3.02e-06	4.18e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PTGS2—atherosclerosis	3.02e-06	4.17e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CD36—atherosclerosis	3.01e-06	4.16e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PIK3CG—atherosclerosis	3e-06	4.15e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—ALB—atherosclerosis	2.99e-06	4.13e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PPARG—atherosclerosis	2.96e-06	4.1e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CXCL8—atherosclerosis	2.93e-06	4.05e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MMP9—atherosclerosis	2.92e-06	4.05e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—INS—atherosclerosis	2.91e-06	4.02e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—NFKB1—atherosclerosis	2.89e-06	4.01e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PPARG—atherosclerosis	2.89e-06	4e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—NOS3—atherosclerosis	2.86e-06	3.95e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PTGS2—atherosclerosis	2.85e-06	3.94e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—MTHFR—atherosclerosis	2.85e-06	3.94e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MAPK8—atherosclerosis	2.84e-06	3.94e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—INS—atherosclerosis	2.84e-06	3.93e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—AKT1—atherosclerosis	2.84e-06	3.93e-05	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—AKT1—atherosclerosis	2.83e-06	3.91e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	2.82e-06	3.91e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PIK3CG—atherosclerosis	2.8e-06	3.88e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PPARA—atherosclerosis	2.79e-06	3.87e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—IL6—atherosclerosis	2.78e-06	3.85e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PPARG—atherosclerosis	2.73e-06	3.77e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—AGT—atherosclerosis	2.71e-06	3.75e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PPARG—atherosclerosis	2.7e-06	3.74e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—INS—atherosclerosis	2.67e-06	3.7e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—HMOX1—atherosclerosis	2.67e-06	3.69e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—ALB—atherosclerosis	2.66e-06	3.69e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—APOE—atherosclerosis	2.65e-06	3.67e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—INS—atherosclerosis	2.65e-06	3.67e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MMP9—atherosclerosis	2.65e-06	3.67e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CAV1—atherosclerosis	2.63e-06	3.64e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—VEGFA—atherosclerosis	2.63e-06	3.64e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—APOA1—atherosclerosis	2.62e-06	3.63e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—NFKB1—atherosclerosis	2.62e-06	3.63e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PTGS2—atherosclerosis	2.61e-06	3.62e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—ALB—atherosclerosis	2.6e-06	3.6e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—STAT3—atherosclerosis	2.6e-06	3.6e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MAPK8—atherosclerosis	2.57e-06	3.56e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—AKT1—atherosclerosis	2.57e-06	3.55e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—APOB—atherosclerosis	2.56e-06	3.54e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—NOS3—atherosclerosis	2.55e-06	3.53e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—NOS3—atherosclerosis	2.49e-06	3.44e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GSTM1—atherosclerosis	2.49e-06	3.44e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MAPK3—atherosclerosis	2.48e-06	3.44e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—ALB—atherosclerosis	2.45e-06	3.39e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—LPL—atherosclerosis	2.44e-06	3.38e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—ALB—atherosclerosis	2.43e-06	3.36e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—TGFB1—atherosclerosis	2.41e-06	3.34e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PIK3CG—atherosclerosis	2.39e-06	3.31e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GPX1—atherosclerosis	2.38e-06	3.3e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—VEGFA—atherosclerosis	2.38e-06	3.29e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—STAT3—atherosclerosis	2.35e-06	3.26e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—NOS3—atherosclerosis	2.34e-06	3.25e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PTGS2—atherosclerosis	2.33e-06	3.23e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—NOS3—atherosclerosis	2.32e-06	3.22e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CD36—atherosclerosis	2.32e-06	3.21e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PPARG—atherosclerosis	2.31e-06	3.2e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PTGS2—atherosclerosis	2.28e-06	3.15e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—INS—atherosclerosis	2.26e-06	3.14e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MAPK3—atherosclerosis	2.25e-06	3.11e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—MTHFR—atherosclerosis	2.2e-06	3.04e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—TGFB1—atherosclerosis	2.18e-06	3.02e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PPARA—atherosclerosis	2.16e-06	2.99e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PTGS2—atherosclerosis	2.14e-06	2.97e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PTGS2—atherosclerosis	2.13e-06	2.94e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—AGT—atherosclerosis	2.09e-06	2.89e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—ALB—atherosclerosis	2.08e-06	2.87e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—APOE—atherosclerosis	2.05e-06	2.83e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CAV1—atherosclerosis	2.03e-06	2.81e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—APOA1—atherosclerosis	2.02e-06	2.8e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—NOS3—atherosclerosis	1.99e-06	2.75e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—AKT1—atherosclerosis	1.92e-06	2.66e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.85e-06	2.56e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PTGS2—atherosclerosis	1.82e-06	2.51e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IL6—atherosclerosis	1.82e-06	2.51e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PPARG—atherosclerosis	1.78e-06	2.47e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—INS—atherosclerosis	1.75e-06	2.42e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—AKT1—atherosclerosis	1.68e-06	2.32e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IL6—atherosclerosis	1.64e-06	2.28e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ALB—atherosclerosis	1.6e-06	2.22e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—AKT1—atherosclerosis	1.55e-06	2.15e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—NOS3—atherosclerosis	1.53e-06	2.12e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—AKT1—atherosclerosis	1.52e-06	2.1e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—AKT1—atherosclerosis	1.52e-06	2.1e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—AKT1—atherosclerosis	1.52e-06	2.1e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—AKT1—atherosclerosis	1.43e-06	1.98e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.4e-06	1.94e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—AKT1—atherosclerosis	1.31e-06	1.82e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—AKT1—atherosclerosis	1.17e-06	1.62e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—AKT1—atherosclerosis	1.14e-06	1.58e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—AKT1—atherosclerosis	1.08e-06	1.49e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—AKT1—atherosclerosis	1.07e-06	1.48e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—AKT1—atherosclerosis	9.13e-07	1.26e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—AKT1—atherosclerosis	7.05e-07	9.76e-06	CbGpPWpGaD
